Merck Japanese Supplier Adds Production Line To Meet Demand For Tafluprost
This article was originally published in PharmAsia News
Asahi Glass Co. April 16 announced a plan to invest ¥800 million for a new production line to manufacture active ingredient tafluprost.
You may also be interested in...
Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.
based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.
Pink Sheet reporters and editors discuss their take-aways from the recent advisory committee meeting on coronavirus vaccine development and approval, as well as the upcoming FDA hearing on Makena’s withdrawal.